Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
Diagnosis
MDS Type
Please select the patient's MDS type.
Treatment History
Has this patient ever received treatment for their MDS?
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Fludarabine
Fludarabine is a chemotherapy medication that may be used in the treatment of many different cancers.
Learn more- 111 clinical trials
- Antimetabolites
- Chemotherapy
Allogeneic Stem Cell Transplant
Allogeneic Stem Cell Transplant is a type of stem cell transplant that utilizes a donor's pre-collected stem cells to rescue the bone marrow from the toxic effects of very high dose chemotherapy.
Learn more- 95 clinical trials
- Allogeneic Stem Cell Transplant
- 85 clinical trials
- Alkylating Agent
- Chemotherapy
Azacitidine
Azacitidine is a type of chemotherapy called a hypomethylating agent that interferes with the growth and spread of cancer cells in the body.
Learn more- 53 clinical trials
- Chemotherapy
- Hypomethylating Agents (HMA)
Tacrolimus
Tacrolimus is an immunosuppressive medication used to help prevent rejection in patients who have had a transplant.
Learn more- 47 clinical trials
Busulfan
Busulfan is a chemotherapy cancer medication that interferes with the growth and spread of cancer cells in the body, and may be used in the treatment of many different cancers.
Learn more- 47 clinical trials
- Alkylating Agent
- Chemotherapy
Mycophenolate Mofetil
Mycophenolate Mofetil is an immunosuppressive medication used to help prevent rejection in patients who have had a transplant.
Learn more- 44 clinical trials
Venetoclax
Venetoclax is a BCL-2 inhibitor that may work by blocking the action of the BCL-2 protein on some cancer cells which can lead to cell death.
Learn more- 43 clinical trials
- BCL-2 Inhibitor
- Has results
Antithymocyte Globulin (ATG)
Antithymocyte Globulin (ATG) is an antibody preparation made from rabbits or horses immune cells altered with human thymocytes. ATG is used to prevent or treat acute cellular rejection after solid organ transplantation and as a therapy for certain other blood disorders.
Learn more- 31 clinical trials
- Immunomodulatory Drug
Decitabine
Decitabine is a type of chemotherapy called a hypomethylating agent that interferes with the growth and spread of cancer cells in the body.
Learn more- 30 clinical trials
- Chemotherapy
- Hypomethylating Agents (HMA)
- Nucleoside Metabolic Inhibitor
Filters
Save & Share
Location
Explore options near your center - or near your patient's home.
Diagnosis
MDS Type
Please select the patient's MDS type.
Treatment History
Has this patient ever received treatment for their MDS?
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Advanced Filters
Trial Enrollment Status
Treatment Classifications
Explore trials based on treatment classification/type.
Trial Type
Phase
Bone Marrow Blasts %
Enter this patient's bone marrow blasts %. If results include a range (5-10%), please use the higher number.
Hypomethylating Agent
Has this patient been treated with a hypomethylating agent (HMA) such as azacitidine and/or decitabine?
Stem Cell Transplant
Has this patient received a prior allogeneic (donor) stem cell transplant?
MDS Classification
Has this patient's MDS been classified as primary (cause unknown) or secondary (treatment related)?